NCT06538038: Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients |
|
|
| Recruiting | N/A | 538 | US | Osimertinib, Tagrisso, Osimertinib + Chemotherapy, Tagrisso, Cisplatin, Carboplatin, Pemetrexed | PrECOG, LLC., ECOG-ACRIN Cancer Research Group | Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation, Stage III Lung Cancer, Stage IV Lung Cancer | 08/28 | 08/29 | | |